ES2194145T3 - Procedimiento para la obtencion de anhidridos mixtos. - Google Patents

Procedimiento para la obtencion de anhidridos mixtos.

Info

Publication number
ES2194145T3
ES2194145T3 ES97121298T ES97121298T ES2194145T3 ES 2194145 T3 ES2194145 T3 ES 2194145T3 ES 97121298 T ES97121298 T ES 97121298T ES 97121298 T ES97121298 T ES 97121298T ES 2194145 T3 ES2194145 T3 ES 2194145T3
Authority
ES
Spain
Prior art keywords
procedure
anhydrates
obtaining mixed
production
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97121298T
Other languages
English (en)
Inventor
Martin Karpf
Rene Trussardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2194145T3 publication Critical patent/ES2194145T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO MEJORADO PARA LA PRODUCCION DE ANHIDRIDOS MEZCLADOS. EL PROCEDIMIENTO SE CARACTERIZA PORQUE SE A\ADE UNA BASE AUXILIAR A LA MEZCLA DE ACIDOS Y DERIVADOS DE ACIDOS. SE CARACTERIZA PARA SU USO ESPECIALMENTE EN LA SINTESIS DE PEPTIDOS Y/O PARA LA PRODUCCION DE SUSTANCIAS FARMACEUTICAMENTE ACTIVAS O LOS CORRESPONDIENTES PRODUCTOS INTERMEDIOS.
ES97121298T 1996-12-11 1997-12-04 Procedimiento para la obtencion de anhidridos mixtos. Expired - Lifetime ES2194145T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96119853 1996-12-11

Publications (1)

Publication Number Publication Date
ES2194145T3 true ES2194145T3 (es) 2003-11-16

Family

ID=8223484

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97121298T Expired - Lifetime ES2194145T3 (es) 1996-12-11 1997-12-04 Procedimiento para la obtencion de anhidridos mixtos.

Country Status (9)

Country Link
US (2) US6489479B1 (es)
EP (1) EP0847994B1 (es)
JP (1) JP3020471B2 (es)
KR (1) KR100269829B1 (es)
CN (1) CN1073080C (es)
AT (1) ATE236880T1 (es)
DE (1) DE59709770D1 (es)
DK (1) DK0847994T3 (es)
ES (1) ES2194145T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753431B2 (en) 2000-06-02 2004-06-22 Sumitomo Chemical Company Limited Production of mixed acid anhydride and amide compound
JP2004003404A (ja) * 2002-06-03 2004-01-08 Hitachi Ltd 電子制御式絞り弁装置、当該装置等に用いられる非接触式回転角度検出装置、ホール素子の信号処理装置。
US7763587B2 (en) * 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
US7375012B2 (en) 2005-02-28 2008-05-20 Pavel Kornilovich Method of forming multilayer film
JP5199337B2 (ja) * 2008-03-18 2013-05-15 三井化学アグロ株式会社 含フッ素アシル酢酸誘導体の製造方法、含フッ素ピラゾールカルボン酸エステル誘導体の製造方法及び含フッ素ピラゾールカルボン酸誘導体の製造方法
WO2012117410A1 (en) * 2011-03-02 2012-09-07 Symed Labs Limited A process for the preparation of n-[2-[(acetylthio) methyl]-1-oxo-3-phenylpropyl] glycine phenyl methyl ester and intermediates thereof
KR101278874B1 (ko) * 2011-09-23 2013-06-26 주식회사 엔지켐생명과학 1-팔미토일-3-아세틸글리세롤의 제조방법 및 이를 이용한 1-팔미토일-2-리놀레오일-3-아세틸글리세롤의 제조방법
US20150266803A1 (en) * 2014-03-24 2015-09-24 Enzychem Lifesciences Corporation Method for preparing monoacetyglycerols and esters thereof
AU2019284745B2 (en) * 2018-06-15 2023-05-11 Yokogawa Electric Corporation Method for producing amide
WO2020175023A1 (ja) * 2019-02-28 2020-09-03 国立大学法人東京工業大学 アミドの製造方法
US20220372069A1 (en) * 2019-09-25 2022-11-24 Nissan Chemical Corporation Method for producing peptide compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61197558A (ja) * 1985-02-25 1986-09-01 Nippon Chemiphar Co Ltd 新規なキナルジン酸アミド誘導体およびその製造法
US4874558A (en) * 1987-05-21 1989-10-17 Indiana University Foundation Polymer catalyzed synthesis of acid anhydrides
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
GB8927913D0 (en) 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
DE59408292D1 (de) 1993-02-19 1999-07-01 Hoffmann La Roche Racemisierungsfreie Herstellung von Amiden und Peptiden in Gegenwart katalytischer Mengen einer N-Hydroxy-Verbindung
US5455353A (en) 1993-03-24 1995-10-03 Hoffmann-La Roche Inc. 4-(benzyl-2-oxo-oxazolidin-5 ylmethyl)N tertbutyl-decahydroisoquinoline-3-carboxamides
DE59407243D1 (de) 1993-07-15 1998-12-10 Hoffmann La Roche Verfahren zur Herstellung eines N-tert.Butylamids
US5591885A (en) 1994-09-23 1997-01-07 Hoffman-La Roche Inc. Process for the preparation of halogenated α-aminoketone compounds
US5523463A (en) 1994-09-23 1996-06-04 Hoffmann-La Roche Inc. Method of producing halogenated and alpha-aminoalchohols

Also Published As

Publication number Publication date
CN1073080C (zh) 2001-10-17
CN1184803A (zh) 1998-06-17
US6562977B2 (en) 2003-05-13
KR100269829B1 (ko) 2000-10-16
EP0847994A1 (de) 1998-06-17
DK0847994T3 (da) 2003-07-28
EP0847994B1 (de) 2003-04-09
ATE236880T1 (de) 2003-04-15
DE59709770D1 (de) 2003-05-15
JP3020471B2 (ja) 2000-03-15
KR19980063985A (ko) 1998-10-07
JPH10175955A (ja) 1998-06-30
US20020077481A1 (en) 2002-06-20
US6489479B1 (en) 2002-12-03

Similar Documents

Publication Publication Date Title
ES2194145T3 (es) Procedimiento para la obtencion de anhidridos mixtos.
BR0112584A (pt) ésteres oxigenados de ácidos benzidroxâmicos de 4-iodofenilamino
BR9407250A (pt) Uso de uma droga tendo atividade vasodilatadora para a fabricação de um medicamento para administração transmucosal transdérmica intranasal e retal
HUP0002486A1 (hu) Lipofil vegyületeket tartalmazó ön-emulgeáló készítmény
SV1997000049A (es) Conjugados de interferones ref. 12614 sv
ES2044870T3 (es) Un procedimiento para la preparacion de nuevos agentes antihipertensivos.
DE69531204D1 (de) Formulierungen fuer faktor ix
ES2170918T3 (es) Inhibidor de proteina quinasa c sustituidos con halo.
ES2096091T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
ES2172748T3 (es) Uso de un inhibidor de aldosa reductasa para la reduccion de daño en tejido no cardiaco.
ES2118584T3 (es) Composicion farmaceutica sublingual o bucal.
BR9810866B1 (pt) composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
HN2001000216A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
ES2139800T3 (es) Preparaciones farmaceuticas liposomales inyectables.
AR003136A1 (es) Peptidos de dolastatin, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y el uso de los mismos para preparar dichas composiciones farmaceuticas.
ES2099764T3 (es) Formulacion a base de diltiazem.
MX9301197A (es) Derivados de indol.
NZ515016A (en) HIV protease inhibitor composition
ES2084709T3 (es) Composicion bioadhesiva y parche.
HUP0002106A2 (hu) Transz-5-klór-2,3,3a,12b-tetrahidro-2-metil-1H-dibenz-[2,3:6,7]oxepino[4,5-c]pirrol aromás szulfonátjai és az ezt tartalmazó gyógyszerkészítmények
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
MX9303933A (es) Compuestos intermedios sinteticos novedosos y procedimiento para la preparacion de los derivados de los aminoacidos.